Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6616 AL 6630

Neuron-derived extracellular vesicles as a liquid biopsy for brain insulin dysregulation in Alzheimer's disease and related disorders

Cleary JA, Kumar A, Craft S, Deep G.

Alzheimers Dement. 2025 Feb;21(2):e14497. doi: 10.1002/alz.14497. Epub 2025 Jan 17.

Retinal and Vascular Findings in Optical Coherence Tomography in Healthy Cognitive Patients With Alzheimer Disease Biomarkers: A Systematic Review and Meta-Analysis

Leal-Bernal C, Noriega-Ramírez S, Álvarez-Martínez JV, Cifuentes-González C, Rojas-Carabali W, Manrique-Samer A, Flórez-Esparza V, Monsalve-García I, Amézquita-Villanueva JS, Mejía-Salgado G, Nava-Mesa MO, de-la-Torre A.

Alzheimer Dis Assoc Disord. 2025 Apr-Jun 01;39(2):140-149. doi: 10.1097/WAD.0000000000000669. Epub 2025 May 13.

Extracellular vesicle-packed microRNAs profiling in Alzheimer's disease: The molecular intermediary between pathology and diagnosis

Arif S, Qazi TJ, Quan Z, Ni J, Li Z, Qiu Y, Qing H.

Ageing Res Rev. 2025 Feb;104:102614. doi: 10.1016/j.arr.2024.102614. Epub 2024 Dec 1.

Signaling Molecules and Diagnosis of Cognitive Disorders: Current State and Prospects

Kvetnoy I, Kheyfets O, Safaniev L, Kheifets V, Mironova E, Kvetnaia T, Mazzoccoli G, Prashchayeu K, Gavrilova A.

Int J Mol Sci. 2025 Dec 29;27(1):372. doi: 10.3390/ijms27010372.

[A new look at blood biomarkers in Alzheimer's patients]

Bogolepova AN, Kovalenko EA, Gileva EA, Makhnovich EV, Gasilova AD, Skvortsov DI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(12):7-13. doi: 10.17116/jnevro20251251217.

Disclosure of plasma p-tau217 measure improves diagnostic confidence in patients with Alzheimer's disease versus syndromes associated with frontotemporal lobar degeneration

Cantoni V, Cotelli MS, Rota M, Alberici A, Libri I, Huber H, Tan K, Ghidoni R, Bellini S, Zetterberg H, Blennow K, Ashton NJ, Borroni B.

Alzheimers Dement. 2025 May;21(5):e70289. doi: 10.1002/alz.70289.

Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology

Suárez-Calvet M, Abdelnour C, Alcolea D, Mendióroz-Iriarte M, Balasa M, Morenas-Rodríguez E, Puig-Pijoan A, Sánchez-Juan P, Villarejo A, Sánchez-Valle R; por el Grupo de trabajo en biomarcadores en sangre del Grupo de Estudio de Conducta y Demencias de la Sociedad Española de Neurología.

Neurologia (Engl Ed). 2025 Sep;40(7):700-712. doi: 10.1016/j.nrleng.2025.07.004. Epub 2025 Jul 18.

Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies

La Joie R, Cummings JL, Dage JL, Galasko D, Ikonomovic MD, Karikari TK, Landau SM, Llibre-Guerra JJ, Mummery CJ, Ossenkoppele R, Price JC, Risacher SL, Smith R, van Dyck CH, Carrillo MC.

Alzheimers Dement. 2025 Nov;21(11):e70997. doi: 10.1002/alz.70997.

Blood-Based Tau as a Biomarker for Early Detection and Monitoring of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Int J Mol Sci. 2025 Oct 23;26(21):10330. doi: 10.3390/ijms262110330.

Associations of depressive symptoms and cortisol with cognitive performance among memory clinic patients

Adedeji DO, Holleman J, Johansson L, Kåreholt I, Aspö M, Hagman G, Akenine U, Overton M, Solomon A, Kivipelto M, Sindi S, Sacuiu SF.

Int Psychogeriatr. 2025 Mar;37(2):100009. doi: 10.1016/j.inpsyc.2024.100009. Epub 2024 Dec 4.

Effect of probiotics on cognitive function and cardiovascular risk factors in mild cognitive impairment and Alzheimer's disease: an umbrella meta-analysis

Xiao B, Fu L, Yang Z, Yu G.

J Health Popul Nutr. 2025 Apr 8;44(1):109. doi: 10.1186/s41043-025-00816-3.

Cerebrospinal Fluid β-Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls

Jensen-Kondering U, Margraf NG, Pikija S, Rak-Frattner K, Malojcic B, Frol S, Pretnar-Oblak J, de la Riva P, Albajar Gomez I, DiFrancesco JC, Bersano A, Kuhlenbäumer G, Storti B.

J Am Heart Assoc. 2025 Aug 5;14(15):e041908. doi: 10.1161/JAHA.125.041908. Epub 2025 Jul 29.

ADNI Biomarker Core: A review of progress since 2004 and future challenges

Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE, Tosun D, DeMarco ML, Brylska M, Wan Y, Burnham S, Sciulli A, Vulaj A, Tropea TF, Chen-Plotkin A, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Jan;21(1):e14264. doi: 10.1002/alz.14264. Epub 2024 Nov 30.

Is early-phase amyloid PET ready for use as neurodegeneration marker?

Boccalini C, Garibotto V.

J Alzheimers Dis. 2025 Oct;107(4):1411-1414. doi: 10.1177/13872877251366671. Epub 2025 Aug 14.

Diagnostic utility of electrophysiological markers for early and differential diagnosis of Alzheimer's, Frontotemporal, and Lewy Body dementias: A systematic review

De Keulenaer S, Van Mossevelde S, Van den Bossche T, Crosiers D, Cras P, Ellender T, Bruffaerts R.

Neurol Sci. 2025 Sep;46(9):4103-4120. doi: 10.1007/s10072-025-08207-6. Epub 2025 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias